Use of Predictors of Recurrence to Plan Therapy for DCIS of the Breast

ONCOLOGY

Volumn 11, Issue 3, 1997, Pages 393-410

  Silverstein, Melvin J ^a   Lagios, Michael D ^b  

^a The Breast Center Inc   (United States)

^b ST MARY S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; CARCINOMA IN SITU; CASE REPORT; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INCIDENCE; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; REVIEW; SURVIVAL RATE; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE;

EID: 0031091388     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Silverstein MJ: Intraductal breast carcinoma: Two decades of progress? Am J Clin Oncol 14(6):534-537, 1991.
2. Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581-1586, 1993.
3. Fisher ER, Constantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Cancer 75-1310-1319, 1995
4. 3a. Mamounas E, Fisher B, Dignam J, et al: Effect of breast irradiation following lumpectomy in intraductal breast cancer (DCIS): Update results from NSABP B-17 Proc Soc Surg Oncol 50:7, 1997
5. Lagios MD, Page DL: Radiation therapy for in situ or localized breast cancer (letter). N Engl J Med 21:1577-1578, 1993.
6. Page DL, Lagios MD: Pathologic analysis of the NSABP-B17 trial: Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer 75:1219-1222, 1995.
7. Silverstein MJ, Barth A, Waisman JR, et al: Predicting local recurrence in patients with intraductal breast carcinoma (DCIS). Proc Am Soc Clin Oncol 14:117, 1995.
8. Silverstein MJ, Barth A, Poller DN, et al: Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31:1425-1427, 1995.
9. Lagios NM, Margolin FR, Westdahl PR, et al: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence Cancer 63:619-624, 1989.
10. Lennington WJ, Jensen RA, Dalton LW, et al: Ductal carcinoma in situ of the breast: Heterogeneity of individual lesions. Cancer 73:118-124, 1994.
11. Patchefsky AS, Schwartz GF, Finkelstein SD, et al: Heterogeneity of intraductal carcinoma of the breast. Cancer 63:731-741, 1989.
12. Morrow M, Schnitt SJ, Harris JR: Ductal carcinoma in situ, in Harris JR, Lippman MC, Morrow M, et al (eds): Diseases of the Breast, pp 355-368. Philadelphia-New York, Lippincott-Raven, 1995.
13. Nemoto T, Vana J, Bedwani RN, et al: Management and survival of female breast cancer: Results of a national survey by The American College of Surgeons. Cancer 45:2917-2924, 1980.
14. SEER Cancer Statistics Review: 1973-1990. National Cancer Institute. NIH Pub No. 93-2789, 1993.
15. Lagios MD: Duct carcinoma in situ: Pathology and treatment. Surg Clin North Am 70:853-871, 1990.
16. Silverstein MJ, Cohlan B, Gierson ED, et al: Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 28(2/3):630-634, 1992.
17. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1997. CA Cancer J Clin 47(1):5-27, 1997.
18. Ashikari R, Hadju SI, Robbins GF: Intraductal carcinoma of the breast Cancer 28:1182-1187, 1971.
19. Barth A, Brenner J, Giuliano AE: Current management of ductal carcinoma in situ. Western J Med 163:360-366, 1995.
20. Stockdale AD, Brierley JD, Whire WF, et al: Radiotherapy for Paget's disease of the nipple: A conservative alternative. Lancet 2 (8664):664-666, 1989.
21. Jensen JA, Handel N, Silverstein MJ: Glandular replacement therapy (CRT) for intraductal breast carcinoma (DCIS) Proc Am Soc Clin Oncol 14:138, 1995.
22. Jensen JA, Handel N, Silverstein MJ: Glandular Replacement Therapy: An argument for a combined surgical approach in the treatment of noninvasive breast cancer. The Breast Journal 2:121-123, 1996.
23. Kroll SS, Ames F, Singletary SE, et al: The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg Gynecol Obstet 172:17-20, 1991.
24. Singletary ES: Skin-sparing mastectomy with immediate breast reconstruction: Is it safe? Breast Diseases: A Yearbook Quarterly 6:259-260, 1995.
25. Silverstein MJ, Handel N, Hoffman RS, et al: The breast center - a multidisciplinary model, in Paterson AHG, Lees AW (eds): Fundamental Problems in Breast Cancer, pp 47-58. Boston, Martinus Nijhoff, 1987.
26. Blichert-Toft M, Brincker H, Andersen J, et al: A Danish randomized trial comparing breast preserving therapy with mastectomy in mammary carcinoma. Acta Oncol 27:671, 1988.
27. Blichert-Toft M, Rose C, Andersen J, et al: Danish randomized trial comparing breast conservative treatment with mastectomy: Six years of life table analysis. J Natl Cancer Inst Monogr 11:9, 1992.
28. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989.
29. Fisher B, Anderson S, Redmond CK, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995.
30. Lichter A, Lippman M, Danforth D, et al: Mastectomy versus breast conserving therapy in the treatment of stage I and II carcinoma of the breast, a randomized trial at The National Cancer Institute. J Clin Oncol 10:976, 1992.
31. Van Dongen JA, Bartelink H, Fentiman IS, et al: Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial Monogr Natl Cancer Inst 11:5-18, 1992.
32. Veronesi U, Saccozzi R, Del Vecchio M, et al: Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6, 1981.
33. Veronesi U, Banfi A, Salvadori B, et al: Breast conservation is the treatment of choice in small breast cancer. Long-term results of a randomized trial. Eur J Cancer 26:668-670, 1990.
34. Page DL, Anderson TJ: Intraductal Barcinoma, in Page DL, Anderson TJ. (eds): Diagnostic Histopathology of the Breast, pp 157-174. New York, Churchill Livingstone, 1987.
35. Tavassoli FA: Intraductal carcinoma, in Tavassoli FA (ed). Pathology of the Breast, pp 229-261. Norwalk, Appleton & Lange, 1992.
36. Rosen PP, Oberman HA. Intraepithelial (Preinvasive or in situ) carcinoma, in Rosen PP, Oberman HA (eds): Atlas of Tumor Pathology -Tumors of the Mammary Gland, pp 119-156. Washington, DC, Armed Forces Institute of Pathology, 1993
37. Aasmundstad TA, Haugen OA: DNA Ploidy in intraductal breast carcinomas. Eur J Cancer 26:956-959, 1992.
38. Meyer J: Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 7:171-180, 1986.
39. Allred DC, Clark GM, Molin R, et al: Over-expression of progression of in situ to invasive breast cancer. Hum Pathol 23:974-979, 1992.
40. Barnes DM, Meyer JS, Gonzalez JG, et al: Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ. Breast Cancer Res Treat 18:11-17, 1991.
41. Bartkova J, Barnes DM, Millis RR, et al: Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Hum Pathol 21:1164-1167, 1990.
42. Bobrow LG, Happerfield LC, Gregory WM, et al: The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol 11:199-207, 1994.
43. Liu E, Thor A, He M, et al: The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 7:1027-1032, 1992.
44. Van de Vijver MJ, Peterse JL, Mooi WJ, et al. Neu-protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319:1239-1245, 1988.
45. Schwartz GF: The role of excision and surveillance alone in subclinical DCIS of the breast. Oncology 8(2):21-26, 1994.
46. Silverstein MJ, Waisman JR, Gierson ED, et al: Radiation therapy for intraductal carcinoma: Is it an equal alternative? Arch Surg 126:424-428, 1991.
47. Solin LJ, Yet IT, Kurtz J, et al: Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment Cancer 71:2532-2542, 1993.
48. Holland R, Peterse JL, Millis R et al: Ductal carcinoma in situ: A proposal for a new classification. Semin Diag Pathol 11(3):167-180, 1994.
49. Kuske RR, Bean JM, Garcia DM, et al: Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 26:391-396, 1993.
50. Silverstein MJ, Poller DN, Waisman JR: Prognostic classification of breast ductal carcinoma in situ. Lancet 345:1154-1557, 1995.
51. Silverstein MJ, Poller DN, Craig PH, et al: A prognostic index for breast ductal carcinoma in situ (abstract). Breast Cancer Res Treat 37(suppl):34, 1996.
52. Lagios MD, Westdahl PR, Margolin FR, et al: Duct Carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50:1309-1314, 1982.
53. Poller DN, Silverstein MJ, Galea M, et al: Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 7:257-262, 1994
54. Bellamy COC, McDonald C, Salter DM, et al: Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization. Hum Pathol 24:16-23, 1993.
55. Sloane JP, Ellman R, Andersen TJ, et al: Consistency of histopathological reporting of breast lesions detected by breast screening: Findings of the UK national external quality assessment (EQA) scheme. Eur J Cancer 30:1414-1419, 1994.
56. Douglas-Jones AG, Gupta SK, Attanoos RL, et al: A critical appraisal of six modern classificaitons of ductal carcinoma in situ of the breast (DCIS): Correlation with grade of associated invasive disease. Histopathology 29:191-409, 1996.
57. Dickson RB, Lippman ME: Growth factors in breast cancer. Endocrine Reviews 16(5):559-589, 1995.
58. Lippman ME: The rational development of biological therapies for breast cancer. Science 259:631-632, 1993.
59. Archer SG, Kemp BL, Gadd M, et al: Ductal carcinoma in situ of the breast. Comedo versus noncomedo subtype nonpredictive of recurrence of contralateral new breast primary. Breast Dis 7:353-360, 1994.
60. Arnesson LG, Smeed S, Fagerberg G, et al. Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br J Surg 76:672-675, 1989.
61. Carter D, Smith RRL: Carcinoma in situ of the breast. Cancer 40:1189-1193, 1977.
62. Ciatto S, Bonardi R, Cataliotti L, et al: Intraductal breast carcinoma. Review of a multicenter series of 350 cases. Tumori 76:552-554, 1990.
63. Farrow JH: Current concepts in the detection and treatment of the earliest of the breast cancers. Cancer 25:468-477, 1970.
64. Fentiman IS, Fagg N, Millis RR, et al: In situ ductal carcinoma of the breast: Implications of disease pattern and treatment. Eur J Surg Oncol 12:261-266, 1986.
65. Haffty BG, Peschel RE, Papadopoulos D, et al: Radiation therapy for ductal carcinoma in situ of the breast. Connecticut Medicine 54:482-484, 1990.
66. Solin LJ, Kurtz J, Fourquet A, et al: Fifteen-year results of breast-conserving surgery and definitive irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754-763, 1996.
67. Lagios MD: Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment. The Breast Journal 1:68-78, 1995.
68. Ottesen GL, Graversen HP, Blichert-Toft M, et al: Ductal carcinoma in situ of the female breast. Short-term results of a prospective nation-wide study. Am J Surg Pathol 16:1183-1196, 1992.
69. Zafrani B, Leroyer A, Fourquet A, et al: Mammographically-detected ductal carcinoma in situ of the breast analysed with a new classification: A study of 127 cases: Correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins and proliferative activity. Semin Diag Pathol 11(3):208-213, 1994.
70. Silverstein MJ, Lagios MD, Craig PH, et al: The Van Nuys Prognostic Index for ductal carcinoma in situ. The Breast Journal 2:38-40, 1996.
71. Silverstein MJ, Lagios MD, Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2261-2274, 1996.
72. Galea MH, Blarney RW, Elston CE, et al: The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207-219, 1992.
73. Bradley SJ, Weaver DW, Bouwman DL: Alternatives in the surgical management of in situ breast cancer. Am Surg 56:428-432, 1990.
74. Fisher ER, Leiming ER, Anderson S, et al: Conservative management of mtraductal carcinoma (DCIS) of the breast. J Surg Oncol 47:139-147, 1991.
75. Kinne DW, Petrek JA, Osborne MP, et al: Breast carcinoma in situ. Arch Surg 124:33-36, 1989.